Ifn-Gamma+874 T/A Polymorphisms Contributes To Cervical Cancer Susceptibility: A Meta-Analysis

na liu,yinglin song,weisong shi
2015-01-01
Abstract:Interferon gamma (IFN-gamma) is a potent proinflammatory cytokine which plays an important role in the antiviral, antiproliferative, and antitumor activities. So our meta-analysis was conducted to evaluate the correlations between common genetic polymorphisms in the IFN-gamma gene and susceptibility to cervical cancer. The +874 polymorphism in IFN gene region reportedly affects cancer risk. In order to derive a more precise estimation of the association, eight clinical case-control studies met all the inclusion criteria and were included in this meta-analysis. A total of 2,375 cancer cases and 2,106 controls were involved in this meta-analysis. Overall, no significant association was detected in allelic model (A allele vs. T allele OR= 0.97, 95% CI, 0.73 similar to 1.28), homozygote comparison (AA vs. TT OR=1.12, 95% CI, 0.68 similar to 1.85), heterozygote comparison (AT vs. TT OR=1.43, 95% CI, 0.97 similar to 1.61), dominant model (AA+AT vs. TT OR=1.19, 95% CI, 0.87 similar to 1.63), nor recessive model (AA vs. AT+TT OR= 0.95, 95% CI, 0.64 similar to 1.40). Subgroup analysis based on ethnicity, genotyping method, and Hardy-Weinberg equilibrium status. Ethnicity suggested that genetic polymorphisms in the IFN-. gene were closely correlated with increased cervical cancer risk among Asians (allele model: OR=1.11, 95% CI=0.61 similar to 2.02, P<0.001; recessive model: OR=0.98, 95% CI=0.36 similar to 2.96, P<0.001; homozygous model: OR=1.43, 95% CI=0.56 similar to 3.65, P=0.001; respectively), but not among Mixed (all P>0.05). In conclusion, the current meta-analysis supported that IFN-gamma genetic polymorphism may contribute to cervical cancer susceptibility, and further well-designed studies with large sample size are warranted to validate our conclusion.
What problem does this paper attempt to address?